Impact of concomitant use of proton pump inhibitors and clopidogrel or ticagrelor on clinical outcomes in patients with acute coronary syndrome

BACKGROUND: There is great debate on the possible adverse interaction between proton pump inhibitors (PPIs) and clopidogrel. In addition, whether the use of PPIs affects the clinical efficacy of ticagrelor remains less known. We aimed to determine the impact of concomitant administration of PPIs and...

Descripción completa

Detalles Bibliográficos
Autores principales: Yan, Yan, Wang, Xiao, Fan, Jing-Yao, Nie, Shao-Ping, Raposeiras-Roubín, Sergio, Abu-Assi, Emad, Henriques, Jose P Simao, D'Ascenzo, Fabrizio, Saucedo, Jorge, González-Juanatey, José R, Wilton, Stephen B, Kikkert, Wouter J, Nuñez-Gil, Iván, Ariza-Sole, Albert, Song, Xian-Tao, Alexopoulos, Dimitrios, Liebetrau, Christoph, Kawaji, Tetsuma, Moretti, Claudio, Huczek, Zenon, Fujii, Toshiharu, Correia, Luis C, Kawashiri, Masa-aki, Kedev, Sasko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Science Press 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4826890/
https://www.ncbi.nlm.nih.gov/pubmed/27103915
http://dx.doi.org/10.11909/j.issn.1671-5411.2016.03.007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4826890/
https://www.ncbi.nlm.nih.gov/pubmed/27103915
http://dx.doi.org/10.11909/j.issn.1671-5411.2016.03.007

Ejemplares similares